Current MRD detection landscape, key considerations for each approach, and current advancements that will contribute to further improvements in MRD detection.
Sponsors who partner with a global central laboratory should expect optimized outcomes resulting from a depth of immuno-oncology and technological expertise and harmonized processes.
Learn 6 critical ways to keep track of the flu to optimize your seasonal flu vaccine development clinical trials.
This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola.
Learn more about different genomic assays that can be used during clinical development and which ones are right for your study.
A critical component in the fight against cancer and optimizing treatment outcomes for patients.
Discover how a comprehensive personalized genomics strategy can help you identify the patients who would most likely benefit from a treatment and suffer the least side effects, ensuring the right drug is used in the right patient at the right time.
Discover the role of the central laboratory in Zika vaccine development and how you can proactively avoid challenges along the development continuum.
How advances in genetic engineering have brought new hope to conquering malaria.
Learn what bioinformatics offers to precision medicine and immuno-oncology.
|
|
|
|
|
|
|
|
|